SIDRA AL-SIBAE: Open Payments
NPI 1295515682 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $559 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $115 |
| ABBVIE INC. | 1 | $113 |
| Gilead Sciences, Inc. | 1 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $86 |
Products named: UBRELVY, XIFAXAN.
Industry payments across PA — which companies pay providers there.
